Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1

Cardiovascular Research

Volumn 91, Issue 3, 2011, Pages 492-501

  Ching, Li Chieh ^a   Kou, Yu Ru ^a,f   Shyue, Song Kun ^b   Su, Kuo Hui ^a   Wei, Jeng ^c   Cheng, Li Ching ^d   Yu, Yuan Bin ^e   Pan, Ching Chian ^a   Lee, Tzong Shyuan ^a,f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

CaMKII; eNOS; Evodiamine; PI3K Akt; TRPV1

Indexed keywords

APOLIPOPROTEIN E; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CAPSAICIN; CAPSAZEPINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EVODIAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VANILLOID RECEPTOR 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CAPSAICIN; CATTLE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; QUINAZOLINES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TRPV CATION CHANNELS;

EID: 79960777946     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr104     Document Type: Article

References (34)

1. Palmer R, Ferrige A, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526. (Pubitemid 17085822)
2. Rikitake Y, Liao JK. Rho GTPases, statins, and nitric oxide. Circ Res 2005;97: 1232-1235.
3. Su KH, Tsai JY, Kou YR, Chiang AN, Hsiao SH, Wu YL et al. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling. Cardiovasc Res 2009;82:468-475.
4. +/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 2001;88:E68-E75.
5. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita N et al. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulateAkt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 2002;90:866-873. (Pubitemid 34633878)
6. Sun J, Liao JK. Functional interaction of endothelial nitric oxide synthase with a voltage-dependent anion channel. Proc Natl Acad Sci USA 2002;99:13108-13113.
7. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389: 816-824. (Pubitemid 27462969)
8. Venkatachalam K, Montell C. TRP channels. Annu Rev Biochem 2007;76:387-417.
9. Pearce LV, Petukhov PA, Szabo T, Kedei N, Bizik F, Kozikowski AP et al. Evodiamine functions as an agonist for the vanilloid receptor TRPV1. Org Biomol Chem 2004;2: 2281-2286.
10. +/ calmodulin modulates TRPV1 activation by capsaicin. J Gen Physiol 2004;123:53-62. (Pubitemid 38082786)
11. Stein AT, Ufret-Vincenty CA, Hua L, Santana LF, Gordon SE. Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol 2006;128:509-522. (Pubitemid 44664629)
12. +/calmodulin-dependent kinase II regulates its vanilloid binding. J Biol Chem 2004;279:7048-7054. (Pubitemid 38248850)
13. Rang WQ, Du YH, Hu CP, Ye F, Tan GS, Deng HW et al. Protective effects of calcitonin gene-related peptide-mediated evodiamine on guinea-pig cardiac anaphylaxis. Naunyn Schmiedebergs Arch Pharmacol 2003;367:306-311. (Pubitemid 36408013)
14. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999;400:452-457. (Pubitemid 29361798)
15. Wang L, Wang DH. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation 2005;112:3617-3623. (Pubitemid 43739540)
16. Yao X, Garland CJ. Recent developments in vascular endothelial cell transient receptor potential channels. Circ Res 2005;97:853-863. (Pubitemid 41552670)
17. Chiou WF, Liao JF, Chen CF. Comparative study on the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J Nat. Prod 1996;59:374-378.
18. Domenicali M, Ros J, Fernandez-Varo G, Cejudo-Martin P, Crespo M, Morales-Ruiz M et al. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Gut 2005;54:522-527. (Pubitemid 40395505)
19. Poblete IM, Orliac ML, Briones R, Adler-Graschinsky E, Huidobro-Toro JP. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed. J Physiol 2005;568:539-551. (Pubitemid 41555456)
20. Watanabe H, Murakami M, Ohba T, Takahashi Y, Ito H. TRP channel and cardiovascular disease. Pharmacol Ther 2008;118:337-351.
21. Rubino A, Burnstock G. Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function. Cardiovasc Res 1996;31:467-479. (Pubitemid 26141484)
22. Folkman J. Angiogenic therapy of the human heart. Circulation 1998;97:645-650.
23. Kamouchi M, Philipp S, Flockerzi V, Wissenbach U, Mamin A, Raeymaekers L et al. Properties of heterologously expressed hTRP3 channels in bovine pulmonary artery endothelial cells. J Physiol 1999;518:345-358. (Pubitemid 29366734)
24. Köhler R, Brakemeier S, Kühn M, Degenhardt C, Buhr H, Pries A et al. Expression of ryanodine receptor type 3 and TRP channels in endothelial cells: comparison of in situ and cultured human endothelial cells. Cardiovasc Res 2001;51:160-168. (Pubitemid 32523065)
25. + current impairs agonist-dependent vasorelaxation in TRP42/2 mice. Nat Cell Biol 2001;3:121-127. (Pubitemid 32118364)
26. Yoshida T, Inoue R, Morii T, Takahashi N, Yamamoto S, Hara Y et al. Nitric oxide activates TRP channels by cysteine S-nitrosylation. Nat Chem Biol 2006;2:596-607. (Pubitemid 44610344)
27. Zhang DX, Mendoza SA, Bubolz AH, Mizuno A, Ge ZD, Li R et al. Transient receptor potential vanilloid type 4-deficient mice exhibit impaired endothelium-dependent relaxation induced by acetylcholine in vitro and in vivo. Hypertension 2009;53: 532-538.
28. + channels. Circ Res 2009;104:987-994.
29. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003;284:R1-R12. (Pubitemid 36008649)
30. Cai H, Liu D, Garcia JG. CaM Kinase II-dependent pathophysiological signalling in endothelial cells. Cardiovasc Res 2008;77:30-34. (Pubitemid 351195142)
31. Ju H, Venema VJ, Marrero MB, Venema RC. Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase. J Biol Chem 1998;273: 24025-24029. (Pubitemid 28435743)
32. Wang L, Wang DH. A novel mechanism contributing to development of Dahl salt-sensitive hypertension: role of the transient receptor potential vanilloid type 1. Hypertension 2006;47:609-614. (Pubitemid 43843884)
33. Huang W, Rubinstein J, Prieto AR, Thang LV, Wang DH. Transient receptor potential vanilloid gene deletion exacerbates inflammation and atypical cardiac remodeling after myocardial infarction. Hypertension 2009;53:243-250.
34. Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J et al. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab 2010;12:130-141.